Biomarkers for detection, prognosis and therapeutic assessment of neurological disorders.

Reviews in the Neurosciences
Sarita SinghPrahlad Kishore Seth

Abstract

Neurological disorders have aroused a significant concern among the health scientists globally, as diseases such as Parkinson's, Alzheimer's and dementia lead to disability and people have to live with them throughout the life. Recent evidence suggests that a number of environmental chemicals such as pesticides (paraquat) and metals (lead and aluminum) are also the cause of these diseases and other neurological disorders. Biomarkers can help in detecting the disorder at the preclinical stage, progression of the disease and key metabolomic alterations permitting identification of potential targets for intervention. A number of biomarkers have been proposed for some neurological disorders based on laboratory and clinical studies. In silico approaches have also been used by some investigators. Yet the ideal biomarker, which can help in early detection and follow-up on treatment and identifying the susceptible populations, is not available. An attempt has therefore been made to review the recent advancements of in silico approaches for discovery of biomarkers and their validation. In silico techniques implemented with multi-omics approaches have potential to provide a fast and accurate approach to identify novel biomarkers.

References

Oct 29, 1990·Brain Research·G PezzoliA Carenzi
Sep 1, 1993·Neurology·J P HubbleW C Koller
Oct 1, 1996·Environmental Health Perspectives·J B Ward, R E Henderson
Oct 17, 1998·Nature·E LeroyM H Polymeropoulos
Aug 10, 2000·Cell·R A Young
Dec 2, 2000·Nature Neuroscience·R BetarbetJ T Greenamyre
May 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D K KimS S Kang
Nov 10, 2001·Annual Review of Genomics and Human Genetics·T IdekerL Hood
Nov 15, 2001·The Journal of Biological Chemistry·Amy B Manning-BogDonato A Di Monte
Nov 24, 2001·Toxicological Sciences : an Official Journal of the Society of Toxicology·S Purkerson-ParkerV C Moser
Mar 2, 2002·Science·Hiroaki Kitano
Aug 28, 2002·Biochemical Society Transactions·O M A el-Agnaf, G B Irvine
Mar 15, 2003·Science·David F Ransohoff
Apr 24, 2003·JAMA : the Journal of the American Medical Association·Trey SunderlandRobert M Cohen
May 20, 2003·The Journal of Biological Chemistry·Ghiam YaminAnthony L Fink
May 24, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Magnus SjögrenKaj Blennow
May 24, 2003·Brain : a Journal of Neurology·Karen E Morrison
Jun 18, 2003·The Biochemical Journal·Richard R DesrosiersRichard Béliveau
Aug 26, 2003·Brain : a Journal of Neurology·Ajit KumarChong S Lee
Sep 27, 2003·Expert Review of Molecular Diagnostics·Stephen Naylor
Nov 11, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Niels AndreasenKaj Blennow
Dec 19, 2003·Annals of Neurology·Giuliano BinettiPaolo Maria Rossini
Feb 19, 2004·Nature Reviews. Genetics·Jonathan B L Bard, Seung Y Rhee
Apr 17, 2004·Science·Enza Maria ValenteNicholas W Wood
Jun 25, 2004·Brain : a Journal of Neurology·A W MichellR A Barker
Oct 8, 2004·Nature Biotechnology·Leroy Hood, Roger M Perlmutter
Apr 29, 2005·Journal of Neurochemistry·Alison L McCormackDonato A Di Monte
Jan 18, 2006·Disease Markers·Michael G HarringtonRobert P Cowan
Jan 19, 2006·Nature Reviews. Genetics·Lars Juhl JensenPeer Bork
Mar 18, 2006·Nature Reviews. Genetics·Matthew James Farrer
Aug 11, 2006·Reviews on Environmental Health·Florianne Monnet-TschudiPaul Honegger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Related Papers

Expert Review of Molecular Diagnostics
Douglas B Kell
Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Julie HoClaudio Rigatto
Expert Review of Proteomics
Mariana P TorrenteKent E Vrana
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Chunxiu HuGuowang Xu
Current Opinion in Organ Transplantation
Valeria R Mas, Daniel G Maluf
© 2022 Meta ULC. All rights reserved